New stent aims to tackle multiple blocked arteries in one go

NCT ID NCT06663696

Recruiting now Disease control Sponsor: Sahajanand Medical Technologies Limited Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a special stent called Supraflex Cruz in 1000 people who have blockages in more than one heart artery. The stent is coated with a drug (sirolimus) that slowly releases to help keep the artery open, and the coating dissolves over time. Researchers want to see if it is safe and works well in real-world patients who need multiple stents.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: sirolimus-eluting stent
What this could lead to: If successful, this stent could provide a safe and effective way to treat multiple blocked arteries in one procedure, reducing the need for repeat surgeries.
What could go wrong: This is a registry study, not a randomized trial, so results may be less definitive. Stents carry risks like blood clots or re-narrowing, and long-term outcomes are still being tracked.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIVESSEL CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PATIENT POPULATION WITH MULTIVESSEL DISEASE

Contacts and locations

Locations

Habib Thameur Hospital
RECRUITING

Tunis, 1089, Tunisia
Sahloul Hospital
RECRUITING

Sousse, 4054, Tunisia

More trials for these conditions

Other studies related to the condition(s) this trial covers.